Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Crimean-Congo Hemorrhagic Fever Virus Vaccine: Past, Present, and Future Publisher



Behboudi E1 ; Kakavandi E2, 3 ; Hamidisofiani V1 ; Ebrahimian A1 ; Shayestehpour M4, 5
Authors

Source: Reviews and Research in Medical Microbiology Published:2022


Abstract

Crimean-Congo hemorrhagic fever (CCHF) has been recognized as a tick-borne infection caused by a member of the Nairoviridae family within the Bunyavirales order, named CCHF virus. CCHF virus is a zoonotic virus, so transferred between vertebrates and humans. Therefore, vaccination in humans and animals might reduce the risk of infection. Currently, there are no globally licensed vaccines or therapeutics for CCHF. Although several studies have been performed on the production of the CCHF vaccine, any of these vaccines were not fully protective. Hence, the development of a new generation of vaccines could contribute to better management of CCHF. In this review, we will discuss on features of these vaccine candidates. © 2022 Lippincott Williams and Wilkins. All rights reserved.
Other Related Docs
15. Vectors of Crimean Congo Hemorrhagic Fever Virus in Iran, Journal of Arthropod-Borne Diseases (2015)
18. A Case Report of Crimean-Congo Hemorrhagic Fever in Iran, Archives of Clinical Infectious Diseases (2023)